In our world of ever-expanding pharmacologic options, we continue to see patients whose treatment may be compromised by non-adherence to our prescribed medication regimens.
Chris Bojrab, MD
How aggressive are you in treating insomnia in your patients, and how do you choose which agent to use?
Bipolar disorder affects approximately 2% to 3% of the population and is the sixth leading cause of disability worldwide.
Healthcare providers are often in a position of influence in terms of the use of supplements, vitamins, and alternative therapies by their patients, but patients are also swayed by the latest medical “experts” in the media.
In standard TMS, direct neuronal activation is limited to a depth of about 1.5 cm in cortical regions. With Deep TMS, the different design of the coil system allows for greater penetration and direct neuronal activation up to a depth of 6 cm, permitting direct excitation or inhibition of deeper brain structures.
Although the diagnostic criteria for the two conditions seem distinctive at first glance, there is a significant degree of variability of symptom presentation.
Do you use metaphors to explain how various medications work to your patients?
Seasonal Affective Disorder (SAD) is more prevalent in northern latitudes. The right type of light box therapy may be helpful.
Generic medications may potentially offer significant savings for patients. However, it's important to understand how these medications are similar and different from brand-name medications.
Over the past few years, a number of companies have begun to offer genetic testing services marketed primarily to psychiatrists. It's important for clinicians to understand how to use these tests to gain valuable clinical information.